Morepen Laboratories Ltd has received approval to export its Loratadine anti-allergy drug to China, marking a strategic expansion into a major pharmaceutical market and confirming their dominance in the US generics market with over 80% share. This approval is significant as it reinforces Morepen's leadership in global healthcare and its capacity to meet growing demand in China.